Lapré J A, De Vries H T, Koeman J H, Van der Meer R
Department of Nutrition, Netherlands Institute for Dairy Research, Ede.
Cancer Res. 1993 Feb 15;53(4):784-9.
Bile acids and fatty acids may promote colon cancer by inducing colonic hyperproliferation. Dietary calcium inhibits the promoting effects of bile acids and fatty acids, possibly by precipitating these surfactants and lowering their cytolytic activity. Because bile acids and fatty acids are products of fat digestion, their effects may be dependent on the type of dietary fat. The effects of the type of dietary fat (energy percentage, 40) and of CaHPO4 supplementation (25 versus 225 mumol/g diet) on the luminal solubility of surfactants, cytolytic activity, epitheliolysis, and in vivo colonic proliferation were studied in rats using Western high-risk diets. The different types of commercially available fats were butter, saturated margarine, and polyunsaturated margarine. Supplemental calcium drastically increased fecal fatty acid excretion, the effect being dependent on the type of fat, and slightly stimulated fecal bile acid excretion. Soluble surfactant concentrations were drastically decreased by calcium supplementation with all three types of dietary fat. Consequently, cytolytic activity of fecal water was decreased by supplemental calcium. These luminal effects of calcium resulted in a lower intestinal epitheliolysis. The compensatory proliferation of the colonic epithelium was decreased by supplemental CaHPO4 for the butter and saturated margarine diets. Despite CaHPO4-dependent decreases in luminal effects and epitheliolysis, no significant decrease in proliferation on the polyunsaturated margarine diet was observed. Multiple regression analysis of soluble surfactants with cytolytic activity (R = 0.76), epitheliolysis (R = 0.74), and colonic proliferation (R = 0.84) showed highly significant associations. Cytolytic activity and epitheliolysis as well as epitheliolysis and proliferation were highly correlated (r = 0.97 and r = 0.88, respectively; n = 36) for control and CaHPO4-supplemented diets, suggesting cause-and-effect relationships. It is concluded that the antiproliferative effect of dietary calcium is mediated by the precipitation of luminal surfactants and is dependent on the type of dietary fat.
胆汁酸和脂肪酸可能通过诱导结肠过度增殖来促进结肠癌。膳食钙可能通过沉淀这些表面活性剂并降低其细胞溶解活性,从而抑制胆汁酸和脂肪酸的促进作用。由于胆汁酸和脂肪酸是脂肪消化的产物,它们的作用可能取决于膳食脂肪的类型。使用西方高风险饮食,研究了膳食脂肪类型(能量百分比为40%)和补充磷酸氢钙(25 μmol/g饮食与225 μmol/g饮食)对表面活性剂腔内溶解度、细胞溶解活性、上皮溶解以及体内结肠增殖的影响。不同类型的市售脂肪有黄油、饱和人造黄油和多不饱和人造黄油。补充钙显著增加了粪便脂肪酸排泄,其效果取决于脂肪类型,并略微刺激了粪便胆汁酸排泄。补充钙后,所有三种膳食脂肪类型的可溶性表面活性剂浓度均显著降低。因此,补充钙降低了粪便水的细胞溶解活性。钙的这些腔内作用导致较低的肠道上皮溶解。对于黄油和饱和人造黄油饮食,补充磷酸氢钙可降低结肠上皮的代偿性增殖。尽管补充磷酸氢钙会使腔内作用和上皮溶解减少,但在多不饱和人造黄油饮食中未观察到增殖有显著降低。对可溶性表面活性剂与细胞溶解活性(R = 0.76)、上皮溶解(R = 0.74)和结肠增殖(R = 0.84)进行多元回归分析,结果显示高度显著的相关性。对于对照饮食和补充磷酸氢钙的饮食,细胞溶解活性与上皮溶解以及上皮溶解与增殖高度相关(分别为r = 0.97和r = 0.88;n = 36),表明存在因果关系。研究得出结论,膳食钙的抗增殖作用是通过腔内表面活性剂的沉淀介导的,并且取决于膳食脂肪的类型。